肝硬化与动脉瘤性蛛网膜下腔出血住院死亡率:倾向校正分析
回顾性分析2003年1月1日至2019年7月31日单中心1419例动脉瘤性蛛网膜下腔出血治疗患者,其中17例(1.2%)合并肝硬化;肝硬化患者住院死亡率35.3%,非肝硬化患者6.8%(P<0.001);倾向校正多因素分析显示肝硬化与住院死亡率相关(OR 12.7,95%CI 3.3-48.7)。
要点
- 肝硬化是aSAH患者住院死亡率的预测因素(OR 12.7,95%CI 3.3-48.7)。
- 肝硬化患者住院死亡率35.3%,非肝硬化患者6.8%(P<0.001)。
- Hunt and Hess分级>3级、Fisher 4级和DCI也与住院死亡率相关。
核心结论
- 肝硬化是aSAH患者住院死亡率的预测因素,且在本研究患者中比DCI或较差的Hunt and Hess分级预测作用更强。
研究设计与样本
- 回顾性分析2003年1月1日至2019年7月31日在一家大型四级中心接受开颅或血管内治疗的aSAH患者,共1419例,其中17例(1.2%)确诊肝硬化。
主要发现
- 肝硬化患者住院死亡率35.3%,非肝硬化患者6.8%(P<0.001)。
- 倾向校正逐步多因素logistic回归显示肝硬化与住院死亡率相关(OR 12.7,95%CI 3.3-48.7)。
- Hunt and Hess分级>3级与住院死亡率相关(OR 3.9,95%CI 2.3-6.4)。
- Fisher 4级与住院死亡率相关(OR 3.7,95%CI 1.3-10.7)。
- DCI与住院死亡率相关(OR 2.4,95%CI 1.5-3.9)。
关键数值与推荐
- 单因素分析中P<0.20的变量纳入倾向校正多因素logistic回归,包括肝硬化、年龄>65岁、Charlson Comorbidity Index>4、动脉瘤大小≥10 mm、Hunt and Hess分级>3级、Fisher 4级、DCI和后循环动脉瘤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Liver cirrhosis is associated with an increased risk of aneurysmal subarachnoid hemorrhage (aSAH). However, large studies analyzing the prognosis of cirrhotic patients after aSAH treatment are lacking. This study explores factors associated with inpatient mortality among aSAH patients with cirrhosis. METHODS: All patients who underwent open or endovascular treatment for an aSAH at a large quaternary center between January 1, 2003, and July 31, 2019, were retrospectively reviewed. Patients were grouped into cirrhosis versus noncirrhosis groups. Univariate analysis determined variables associated with inpatient mortality. Variables with P < 0.20 were included in a propensity-adjusted multivariable logistic regression analysis to predict inpatient mortality. RESULTS: A total of 1419 patients were treated for aSAH; 17 (1.2%) had confirmed cirrhosis. Inpatient mortality was significantly higher among cirrhotic patients than noncirrhotic patients (35.3% vs. 6.8%; P < 0.001). In the univariate analysis for inpatient mortality, the variables cirrhosis, age >65 years, Charlson Comorbidity Index >4, aneurysm size ≥10 mm, Hunt and Hess grade >3, Fisher grade 4, delayed cerebral ischemia (DCI), and posterior circulation aneurysm had P < 0.20 and were included in the multivariable analysis. The propensity-adjusted stepwise multivariable logistic regression analysis showed that cirrhosis (odds ratio [OR]: 12.7, 95% confidence interval [CI]: 3.3-48.7), Hunt and Hess grade >3 (OR: 3.9, 95% CI: 2.3-6.4), Fisher grade 4 (OR: 3.7, 95% CI: 1.3-10.7), and DCI (OR: 2.4, 95% CI: 1.5-3.9) were associated with inpatient mortality (P ≤ 0.01). CONCLUSIONS: Cirrhosis was a predictor of inpatient mortality among aSAH patients and was a stronger predictor than DCI or a poor Hunt and Hess grade among patients in this study.
引用
- Catapano JS, Lee KE, Rumalla K, et al. Liver Cirrhosis and Inpatient Mortality in Aneurysmal Subarachnoid Hemorrhage: A Propensity-Adjusted Analysis. World Neurosurg. 2022. PMID: 36055622. doi:10.1016/j.wneu.2022.08.113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。